Ario Pharma

Innovation in respiratory medicine.

Ario Pharma is a clinical-stage company developing a novel therapeutic approach to overactive bladder, an area of significant unmet medical need. The Company’s development compound, XEN-D0501, targets a well-established, but not yet exploited mechanism for overactive bladder, and is about to start Phase two clinical development.

  • CEO Tim Brears, PhD
  • Industry Biotech